Is there a role for molecular testing for low-risk differentiated thyroid cancer? a cost-effectiveness analysis

HIGHLIGHTS

  • who: Idit Tessler and collaborators from the Department of Otolaryngology Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel have published the article: Is There a Role for Molecular Testing for Low-Risk Differentiated Thyroid Cancer? A Cost-Effectiveness Analysis, in the Journal: (JOURNAL)
  • what: The analysis methodology and results are reported according to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) guidelines, that were created for reporting evaluation of economic health interventions of.. The model is based on a simulated cohort. This study is . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?